Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated
devices) that quantify mobility in unsupervised, daily living environments are emerging as …

Background Patients with chronic diseases commonly report fears of illness or symptoms
recurring or worsening. These fears have been addressed from an illness-specific …

Inertial measurement units (IMUs) have a long-lasting popularity in a variety of industrial
applications from navigation systems to guidance and robotics. Their use in clinical practice …

Introduction Given the high rate of falls during walking in people with idiopathic Parkinson's
disease (PD), identifying at risk individuals and develo** targeted interventions to reduce …

Gait speed often referred as the sixth vital sign is the most powerful biomarker of mobility.
While a clinical setting allows the estimation of gait speed under controlled conditions that …

About 422 million people worldwide have diabetes and approximately one-third of them
have a major risk factor for diabetic foot ulcers, including poor sensation in their feet from …

Background The main objective of this paper is to develop and test the ability of the Leap
Motion controller (LMC) to assess the motor dysfunction in patients with Parkinson disease …

This study assessed the concurrent validity and test–retest-reliability of the Apple Health app
on iPhone for measuring gait parameters in different age groups. Twenty-seven children, 28 …

Most wearable sensor studies in Parkinson's disease have been conducted in the clinic and
thus may not be a true representation of everyday symptoms and symptom variation. Our …

Background: The emergence of new technologies measuring outcomes in Parkinson's
disease (PD) to complement the existing clinical rating scales has introduced the possibility …